Zymeworks (ZYME) Selling, General & Administrative (2021 - 2026)

Zymeworks (ZYME) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - 15.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.07 Mn
Dec 31, 2025 15.43 Mn
Sep 30, 2025 14.15 Mn
Jun 30, 2025 14.95 Mn
Mar 31, 2025 16.99 Mn
Dec 31, 2024 16.19 Mn
Sep 30, 2024 13.85 Mn
Jun 30, 2024 15.68 Mn
Mar 31, 2024 15.79 Mn
Dec 31, 2023 14.82 Mn
Sep 30, 2023 16.97 Mn
Jun 30, 2023 21.71 Mn
Mar 31, 2023 16.95 Mn
Dec 31, 2022 30.13 Mn
Sep 30, 2022 15.89 Mn
Jun 30, 2022 15.24 Mn
Mar 31, 2022 12.09 Mn
Dec 31, 2021 5.85 Mn
Sep 30, 2021 15.47 Mn